Date Filed | Type | Description |
06/02/2023 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 22,355 options to buy
@ $2.73, valued at
$61k
|
|
01/03/2023 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 55,555 shares
@ $1.53, valued at
$85k
|
|
12/05/2022 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Bought 35,000 shares
@ $1.3855, valued at
$48.5k
|
|
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2022 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 23,762 shares
@ $3.58, valued at
$85.1k
|
|
07/16/2021 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 13,150 options to buy
@ $3.64, valued at
$47.9k
|
|
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/04/2020 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Bought 5,000 shares
@ $5.4994, valued at
$27.5k
Bought 5,000 shares
@ $5.24, valued at
$26.2k
|
|
06/02/2020 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 10,168 shares
@ $4.59, valued at
$46.7k
Granted 19,220 options to buy
@ $4.64, valued at
$89.2k
|
|
08/19/2019 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Bought 7,840 shares
@ $2.556, valued at
$20k
|
|
06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2019 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Bought 19,000 shares
@ $2.8, valued at
$53.2k
|
|
12/11/2018 |
4
| Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Bought 6,250 shares
@ $4, valued at
$25k
|
|
12/06/2018 |
3
| Pilnik Richard D. (Director) has filed a Form 3 on DiaMedica Therapeutics Inc. |